mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.003 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.14 |
0.003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.004 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |